Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations in diagnosis and treatment.

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced Parkinson's disease, Supernus Pharmaceuticals announced on Tuesday.. The ...

Vyalev offers patients a steady flow of dopamine to counter the tremors associated with the disease Last Updated: Oct. 17, 2024 at 11:34 a.m. ET First Published: Oct. 17, 2024 at 8:12 a.m. ET Share ...

Researchers estimate that 89% of people with Parkinson's disease have speech and voice disorders including disorders of laryngeal, respiratory and articulatory function.

As symptoms progress, people with Parkinson’s disease may struggle to walk, speak and carry out other basic tasks. An estimated three-quarters of people living with Parkinson’s for more than ...

But a BBC investigation has highlighted that some drug treatments for restless leg syndrome and Parkinson's disease can lead to such risky behavior.. More than 150,000 people in the UK live with ...

Dr. Helen Bronte-Stewart developed adaptive Deep Brain Stimulation (aDBS) as a more responsive and refined treatment for the symptoms of Parkinson’s Disease - the FDA approved aDBS for the ...

Scientists have finally pinned down a protein that’s largely responsible for Parkinson’s disease. Known as PINK1, the protein has been linked to the disease for decades but its structure and ...

Clinical trial tests novel stem-cell treatment for Parkinson's disease. ScienceDaily. Retrieved July 12, 2025 from www.sciencedaily.com / releases / 2025 / 03 / 250309203153.htm.